WRF
KYNB

Waddell & Reed Financial’s Kyntra Bio KYNB Stock Holding History

Waddell & Reed Financial’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-71,379
Closed -$36.9M – 589
2016
Q3 		$36.9M Sell
71,379
-9,881
-12% -$4.65M 0.08% 248
2016
Q2 		$33.3M Hold
81,260
– – 0.07% 251
2016
Q1 		$43.3M Hold
81,260
– – 0.08% 213
2015
Q4 		$61.9M Hold
81,260
– – 0.1% 188
2015
Q3 		$44.5M Buy
81,260
+60
+0.1% +$36.3K 0.07% 225
2015
Q2 		$47.7M Buy
81,200
+27,488
+51% +$16M 0.07% 226
2015
Q1 		$42.1M Buy
53,712
+14,892
+38% +$11.5M 0.06% 244
2014
Q4 		$26.5M Buy
+38,820
New +$25M 0.04% 300

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Waddell & Reed Financial's KYNB Position: Q4 2016 in Review

Waddell & Reed Financial sold out of Kyntra Bio (KYNB) in Q4 2016, closing a stake of 71,379 shares — an estimated $36.9M sold.

Waddell & Reed Financial first reported a position in KYNB in Q4 2014 and held it in 8 quarters. The position peaked at $61.9M in Q4 2015. 140 funds tracked by Wall St. Rank hold KYNB as of Q4 2016.

  • Waddell & Reed Financial reported no remaining Kyntra Bio position as of Q4 2016 after selling out during the quarter.
  • Waddell & Reed Financial sold 71,379 Kyntra Bio shares in Q4 2016, an estimated $36.9M.
  • Waddell & Reed Financial first reported a position in Kyntra Bio in Q4 2014 and held it in 8 quarters.
  • Waddell & Reed Financial's Kyntra Bio position peaked at $61.9M in Q4 2015.
  • 140 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2016.

Based on Waddell & Reed Financial's 13F filing for Q4 2016, filed 14 Feb 2017.